TG Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TGTX and other ETFs, options, and stocks.About TGTX
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib.
CEOMichael Sean Weiss
CEOMichael Sean Weiss
Employees338
Employees338
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded1993
Founded1993
Employees338
Employees338
TGTX Key Statistics
Market cap6.20B
Market cap6.20B
Price-Earnings ratio270.85
Price-Earnings ratio270.85
Dividend yield—
Dividend yield—
Average volume2.86M
Average volume2.86M
High today$40.35
High today$40.35
Low today$38.47
Low today$38.47
Open price$38.75
Open price$38.75
Volume1.82M
Volume1.82M
52 Week high$43.32
52 Week high$43.32
52 Week low$12.93
52 Week low$12.93
TGTX News
Simply Wall St 7d
Exploring US High Growth Tech StocksOver the last 7 days, the United States market has experienced a 3.0% drop, although it has risen by 4.6% over the past year, with earnings anticipated to grow...
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
0%
Sell
14.3%